Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
HHD is a kidney replacement modality for patients with end-stage kidney disease (ESKD) that can be performed safely in the patient’s home environment. Assistance of a trained caregiver or qualified hemodialysis nurse is a requirement. The frequency of treatment for HHD can vary per individual patient. HHD can be performed as conventional HHD, with treatments 3 days a week for 3 to 4 hours or longer each time. It can also be performed as short daily HHD, occurring 5 to 7 times a week for shorter duration. Lastly, it can be performed overnight as nocturnal NHHD where treatments normally last 6 to 8 hours.
The 2010 United States Renal Data System (USRDS) report showed that 0.51% of incident dialysis patients were undergoing HHD. Based on the 2015 USRDS report, the use of HHD by incident ESKD patients increased by 222% from 2007 to 2013. Even with the large relative rise in HHD, its overall utilization as a home dialysis modality is significantly lower than that of peritoneal dialysis (PD). Home dialysis, either HHD or PD, was utilized by 9.1% of all patients undergoing dialysis as of 2013.
In the United States HHD is performed with a “low-flow systems” (L-FS) machine. The most frequently used L-FS machine in the United States is the NxStage System. The NxStage machine is portable; it weighs 32 kg (71 lbs) and is 15 × 15 inches. Dialysate for the machine is provided in two ways. Delivery of 5-L dialysate bags can be made to a patient’s home, with four to six bags needed for short daily dialysis. These bags are convenient when patients are traveling. Alternatively, there is a fluid generator (PureFlow) that can prepare up to 60 L of dialysate (enough for two to three treatments) using a filtering system within the machine and connection to a tap water source.
The common conventional in-center dialysis machine is a “single-pass system” (SPS) machine. A SPS machine produces dialysate within the machine by proportionally mixing acid and base concentrates with a purified water source. The dialysate then moves as a single-pass, high-flow fluid to the dialyzer for transmembrane contact with the patient’s blood. A SPS machine typically uses a dialysate flow to blood flow (Qd:Qb) ratio of 2:1. With an L-FS machine (like the NxStage), the flow rates are reversed so that Qd:Qb is between 1:2 and 1:3. This permits a more complete equilibrium between dialysate and patient’s blood, ultimately allowing for the use of less dialysate.
Patients are able to use a tunneled central venous catheters (CVCs) or arteriovenous fistulae (AVF) to connect themselves to an HHD machine. As in conventional in-center hemodialysis, an AVF is preferred over a CVC, given the increased risk of blood stream infections associated with CVCs.
The conventional method of repeated cannulation of an AVF involves using sharp-tip needles and rotating needle puncture sites (“rope-ladder technique”) with each successive dialysis treatments. A “buttonhole” is a constant fibrous tract established by repeated puncture followed by small eschar formation of the same site. Recannulation of the same two sites eventually allows access with a blunt-tip needle.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here